{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:31:36Z","timestamp":1788517896771,"version":"build-2803163510"},"reference-count":125,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cholangiocarcinoma (CCA) is a rare but highly invasive cancer, with its incidence rising in recent years. Currently, surgery remains the most definitive therapeutic option for CCA. However, similar to other malignancies, most CCA patients are not eligible for surgical intervention at the time of diagnosis. The chemotherapeutic regimen of gemcitabine combined with cisplatin is the standard treatment for advanced CCA, but its effectiveness is often hampered by therapeutic resistance. Recent research highlights the remarkable plasticity of tumor-associated macrophages (TAMs) within the tumor microenvironment (TME). TAMs play a crucial dual role in either promoting or suppressing tumor development, depending on the factors that polarize them toward pro-tumorigenic or anti-tumorigenic phenotypes, as well as their interactions with cancer cells and other stromal components. In this review, we critically examine recent studies on TAMs in CCA, detailing the expression patterns and prognostic significance of different TAM subtypes in CCA, the mechanisms by which TAMs influence CCA progression and immune evasion, and the potential for reprogramming TAMs to enhance anticancer therapies. This review aims to provide a framework for deeper future research.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1451474","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T04:27:08Z","timestamp":1725337628000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Tumor-associated macrophages: orchestrators of cholangiocarcinoma progression"],"prefix":"10.3389","volume":"15","author":[{"given":"Fei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2021.1864325","article-title":"BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care","volume":"15","author":"Rizzo","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1023\/A:1013747228572","article-title":"Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy","volume":"12","author":"Donato","year":"2001","journal-title":"Cancer Causes Control"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.05.020","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study","volume":"5","author":"Welzel","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0186643","DOI":"10.1371\/journal.pone.0186643","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare","volume":"12","author":"Petrick","year":"2017","journal-title":"PloS One"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.5009\/gnl17102","article-title":"Liver fluke-associated biliary tract cancer","volume":"12","author":"Prueksapanich","year":"2018","journal-title":"Gut Liver"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.026","article-title":"Emerging molecular therapeutic targets for cholangiocarcinoma","volume":"67","author":"Rizvi","year":"2017","journal-title":"J Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00196-5","article-title":"El-Khoueiry A et\u00a0al: Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study","volume":"6","author":"Javle","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006230","article-title":"The NR_109\/FUBP1\/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development","volume":"11","author":"Zhang","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00813-7","article-title":"TAM family kinases as therapeutic targets at the interface of cancer and immunity","volume":"20","author":"DeRyckere","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000002252","article-title":"Macarthur J et\u00a0al: Increased Circulating Chemokines and Macrophage Recruitment in Growing Vestibular Schwannomas","volume":"92","author":"Hannan","year":"2023","journal-title":"Neurosurgery"},{"key":"B13","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.ccell.2019.02.009","article-title":"Lin EY et\u00a0al: Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets","volume":"35","author":"Cassetta","year":"2019","journal-title":"Cancer Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e2107394119","DOI":"10.1073\/pnas.2107394119","article-title":"Martin-Jaular L et\u00a0al: Extracellular vesicles from triple negative breast cancer promote pro-inflammatory macrophages associated with better clinical outcome","volume":"119","author":"Tkach","year":"2022","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.02.036","article-title":"Liu D et\u00a0al: FGF19\/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2","volume":"79","author":"Xie","year":"2023","journal-title":"J Hepatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s13046-023-02860-5","article-title":"FAM171B stabilizes vimentin and enhances CCL2-mediated TAM infiltration to promote bladder cancer progression","volume":"42","author":"Hu","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3337","article-title":"Teijeiro V et\u00a0al: CSF-1R inhibition alters macrophage polarization and blocks glioma progression","volume":"19","author":"Pyonteck","year":"2013","journal-title":"Nat Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318419","article-title":"Zhang Y et\u00a0al: Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade","volume":"68","author":"Zhu","year":"2019","journal-title":"Gut"},{"key":"B19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13045-020-00991-2","article-title":"Li X et\u00a0al: Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer","volume":"13","author":"Zhao","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005560","article-title":"Antitumor strategies targeting macrophages: the importance of considering the differences in differentiation\/polarization processes between human and mouse macrophages","volume":"10","author":"Monnier","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-019-1022-2","article-title":"Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment","volume":"18","author":"Myers","year":"2019","journal-title":"Mol Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-023-00846-8","article-title":"Therapeutic targeting of the functionally elusive TAM receptor family","volume":"23","author":"Miao","year":"2024","journal-title":"Nat Rev Drug Discovery"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.02.020","article-title":"Macrophages at the interface of the co-evolving cancer ecosystem","volume":"186","author":"Kloosterman","year":"2023","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/imr.13267","article-title":"TAM receptors in phagocytosis: Beyond the mere internalization of particles","volume":"319","author":"Burstyn-Cohen","year":"2023","journal-title":"Immunol Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.immuni.2023.06.017","article-title":"Hambardzumyan D et\u00a0al: Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression","volume":"56","author":"Sattiraju","year":"2023","journal-title":"Immunity"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7150\/thno.52435","article-title":"Wang L et\u00a0al: ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-3350","article-title":"Apostolov E et\u00a0al: Reversal of Lactate and PD-1-mediated Macrophage Immunosuppression Controls Growth of PTEN\/p53-deficient Prostate Cancer","volume":"29","author":"Chaudagar","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nature22396","article-title":"Corey D et\u00a0al: PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.1038\/s41467-021-27018-9","article-title":"Zhang Y et\u00a0al: Interrogation of the microenvironmental landscape in spinal ependymomas reveals dual functions of tumor-associated macrophages","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.09.008","article-title":"Macrophage metabolism controls tumor blood vessel morphogenesis and metastasis","volume":"24","author":"Wenes","year":"2016","journal-title":"Cell Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, mechanisms, and significance of macrophage plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J Clin Invest"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000952","article-title":"Cytokines and costimulation in acute graft-versus-host disease","volume":"136","author":"Hill","year":"2020","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/BOR.0000000000000491","article-title":"How does abatacept really work in rheumatoid arthritis","volume":"30","author":"Bonelli","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nri3818","article-title":"The ins and outs of MHC class II-mediated antigen processing and presentation","volume":"15","author":"Roche","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01084","article-title":"Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively Activated Macrophages","volume":"10","author":"Orecchioni","year":"2019","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1038\/s41467-022-29659-w","article-title":"Guillaumond F et\u00a0al: Sympathetic axonal sprouting induces changes in macrophage populations and protects against pancreatic cancer","volume":"13","author":"Guillot","year":"2022","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","first-page":"154757","DOI":"10.1016\/j.phymed.2023.154757","article-title":"Fu C et\u00a0al: Glycyrrhetinic acid suppresses breast cancer metastasis by inhibiting M2-like macrophage polarization via activating JNK1\/2 signaling","volume":"114","author":"Cheng","year":"2023","journal-title":"Phytomedicine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1016\/j.immuni.2023.07.014","article-title":"Freeley S et\u00a0al: Loss of CD4(+) T cell-intrinsic arginase 1 accelerates Th1 response kinetics and reduces lung pathology during influenza infection","volume":"56","author":"West","year":"2023","journal-title":"Immunity"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04082-1","article-title":"Sonomura K et\u00a0al: B cell-derived GABA elicits IL-10(+) macrophages to limit anti-tumour immunity","volume":"599","author":"Zhang","year":"2021","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"110648","DOI":"10.1016\/j.intimp.2023.110648","article-title":"Dual anti-PD-(L)1\/TGF-beta inhibitors in cancer immunotherapy - Updated","volume":"122","author":"Karami","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"5665","DOI":"10.1038\/s41467-024-49885-8","article-title":"Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy response","volume":"15","author":"Coulton","year":"2024","journal-title":"Nat Commun"},{"key":"B44","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12967-022-03342-6","article-title":"SIRPalpha and PD1 expression on tumor-associated macrophage predict prognosis of intrahepatic cholangiocarcinoma","volume":"20","author":"Yang","year":"2022","journal-title":"J Transl Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2174\/0115680096276605240108112135","article-title":"IL-33\/ST2 signaling and its correlation with macrophage heterogeneity and clinicopathologic features in human intrahepatic cholangiocarcinoma","volume":"24","author":"Yasen","year":"2024","journal-title":"Curr Cancer Drug Targets"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.967982","article-title":"Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma","volume":"12","author":"Xu","year":"2022","journal-title":"Front Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v8.i26.1093","article-title":"Cholangiocarcinoma, gone without the Wnt","volume":"8","author":"Noll","year":"2016","journal-title":"World J Hepatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2010.04200.x","article-title":"Circulating CD14(+) CD16(+) monocyte levels predict tissue invasive character of cholangiocarcinoma","volume":"161","author":"Subimerb","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.08.012","article-title":"Alpini G et\u00a0al: Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages","volume":"66","author":"Raggi","year":"2017","journal-title":"J Hepatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01614.x","article-title":"Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma","volume":"101","author":"Hasita","year":"2010","journal-title":"Cancer Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1038\/s41467-022-29164-0","article-title":"Yang S et\u00a0al: Single-cell transcriptomic analysis suggests two molecularly subtypes of intrahepatic cholangiocarcinoma","volume":"13","author":"Song","year":"2022","journal-title":"Nat Commun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i8.804","article-title":"Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer","volume":"26","author":"Zhu","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1610687","DOI":"10.3389\/pore.2022.1610687","article-title":"Immunological role and prognostic value of SPARCL1 in pan-cancer analysis","volume":"28","author":"He","year":"2022","journal-title":"Pathol Oncol Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.03.016","article-title":"Yang Q et\u00a0al: FASN-mediated fatty acid biosynthesis remodels immune environment in Clonorchis sinensis infection-related intrahepatic cholangiocarcinoma","volume":"82","author":"Xu","year":"2024","journal-title":"J Hepatol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2023.10.007","article-title":"Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies","volume":"44","author":"Nasir","year":"2023","journal-title":"Trends Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cancergen.2023.04.001","article-title":"Metabolic-related gene signatures for survival prediction and immune cell subtypes associated with prognosis in intrahepatic cholangiocarcinoma","author":"Jin","year":"2023","journal-title":"Cancer Genet"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e8458","DOI":"10.7717\/peerj.8458","article-title":"CD86(+)\/CD206(+) tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma","volume":"8","author":"Sun","year":"2020","journal-title":"PeerJ"},{"key":"B59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13045-022-01253-z","article-title":"Osipov A et\u00a0al: Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses","volume":"15","author":"Xia","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-014-0989-y","article-title":"Macrophage density and macrophage colony-stimulating factor expression predict the postoperative prognosis in patients with intrahepatic cholangiocarcinoma","volume":"45","author":"Oishi","year":"2015","journal-title":"Surg Today"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1169537","article-title":"Preoperative immunological plasma markers TRAIL, CSF1 and TIE2 predict survival after resection for biliary tract cancer","volume":"13","author":"Jansson","year":"2023","journal-title":"Front Oncol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1186\/s12885-015-1795-7","article-title":"Schierle K et\u00a0al: Prognostic significance of macrophage invasion in hilar cholangiocarcinoma","volume":"15","author":"Atanasov","year":"2015","journal-title":"BMC Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9618","article-title":"Prognostic value of inflammation-based indexes for intrahepatic cholangiocarcinoma following curative resection","volume":"17","author":"Wu","year":"2019","journal-title":"Oncol Lett"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324109","article-title":"Keilson JM et\u00a0al: GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity","volume":"71","author":"Ruffolo","year":"2022","journal-title":"Gut"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.11.018","article-title":"Robson AJ et\u00a0al: TWEAK\/Fn14 signalling promotes cholangiocarcinoma niche formation and progression","volume":"74","author":"Dwyer","year":"2021","journal-title":"J Hepatol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2022_220324N333","article-title":"SPARC induces M2 polarization of macrophages to promote proliferation, migration, and angiogenesis of cholangiocarcinoma cells","volume":"69","author":"Deng","year":"2022","journal-title":"Neoplasma"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.605877","article-title":"Zhao Z et\u00a0al: Long Non-Coding RNA PCAT6 Induces M2 Polarization of Macrophages in Cholangiocarcinoma via Modulating miR-326 and RhoA-ROCK Signaling Pathway","volume":"10","author":"Tu","year":"2020","journal-title":"Front Oncol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1186\/s12967-023-04804-1","article-title":"ALOX5 acts as a key role in regulating the immune microenvironment in intrahepatic cholangiocarcinoma, recruiting tumor-associated macrophages through PI3K pathway","volume":"21","author":"Chen","year":"2023","journal-title":"J Transl Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15383","article-title":"Cambridge WA et\u00a0al: DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti-DKK1 therapeutic DKN-01","volume":"43","author":"Jarman","year":"2023","journal-title":"Liver Int"},{"key":"B70","doi-asserted-by":"publisher","first-page":"102054","DOI":"10.1016\/j.omtn.2023.102054","article-title":"Matsumoto K et\u00a0al: MicroRNA-451a inhibits gemcitabine-refractory biliary tract cancer progression by suppressing the MIF-mediated PI3K\/AKT pathway","volume":"34","author":"Obata","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10110460","article-title":"Fucosyl-agalactosyl igG(1) induces cholangiocarcinoma metastasis and early recurrence by activating tumor-associated macrophage","volume":"10","author":"Chang","year":"2018","journal-title":"Cancers (Basel)"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2102206118","article-title":"Yu Q et\u00a0al: Csi-let-7a-5p delivered by extracellular vesicles from a liver fluke activates M1-like macrophages and exacerbates biliary injuries","volume":"118","author":"Yan","year":"2021","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-023-10557-7","article-title":"Reciprocal interaction of cancer stem cells of cholangiocarcinoma with macrophage","volume":"19","author":"Wang","year":"2023","journal-title":"Stem Cell Rev Rep"},{"key":"B74","doi-asserted-by":"publisher","first-page":"106564","DOI":"10.1016\/j.phrs.2022.106564","article-title":"Xie J et\u00a0al: SHH\/GLI2-TGF-beta1 feedback loop between cancer cells and tumor-associated macrophages maintains epithelial-mesenchymal transition and endoplasmic reticulum homeostasis in cholangiocarcinoma","volume":"187","author":"Chen","year":"2023","journal-title":"Pharmacol Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2018.10.007","article-title":"Attenuation of CD47-SIRPalpha signal in cholangiocarcinoma potentiates tumor-associated macrophage-mediated phagocytosis and suppresses intrahepatic metastasis","volume":"12","author":"Vaeteewoottacharn","year":"2019","journal-title":"Transl Oncol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-021-02235-8","article-title":"Macrophages-aPKC(i)-CCL5 feedback loop modulates the progression and chemoresistance in cholangiocarcinoma","volume":"41","author":"Yang","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16068","article-title":"Yin B et\u00a0al: IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18\/STAT3 pathway","volume":"115","author":"Zhou","year":"2024","journal-title":"Cancer Sci"},{"key":"B78","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1186\/s12935-020-01687-w","article-title":"Intrahepatic cholangiocarcinoma induced M2-polarized tumor-associated macrophages facilitate tumor growth and invasiveness","volume":"20","author":"Yuan","year":"2020","journal-title":"Cancer Cell Int"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfy280","article-title":"Exposure to 1,2-dichloropropane upregulates the expression of activation-induced cytidine deaminase (AID) in human cholangiocytes co-cultured with macrophages","volume":"168","author":"Zong","year":"2019","journal-title":"Toxicol Sci"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.131","article-title":"STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression","volume":"21","author":"Dokduang","year":"2014","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat Rev Drug Discovery"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006454","article-title":"High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis","volume":"11","author":"Jung","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.11.037","article-title":"Rosato U et\u00a0al: CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma","volume":"74","author":"Diggs","year":"2021","journal-title":"J Hepatol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2011.11.030","article-title":"Asahina D et\u00a0al: Macrophage-capping protein as a tissue biomarker for prediction of response to gemcitabine treatment and prognosis in cholangiocarcinoma","volume":"75","author":"Morofuji","year":"2012","journal-title":"J Proteomics"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1251648","article-title":"M2 macrophage inhibits the antitumor effects of Lenvatinib on intrahepatic cholangiocarcinoma","volume":"14","author":"Yang","year":"2023","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092454","article-title":"Anti-cancer activity of verteporfin in cholangiocarcinoma","volume":"15","author":"Golino","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e0189628","DOI":"10.1371\/journal.pone.0189628","article-title":"Lupeol and stigmasterol suppress tumor angiogenesis and inhibit cholangiocarcinoma growth in mice via downregulation of tumor necrosis factor-alpha","volume":"12","author":"Kangsamaksin","year":"2017","journal-title":"PloS One"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-21-1101","article-title":"Cheng F et\u00a0al: Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell RNA Sequencing-Assisted Multiomics Analysis","volume":"10","author":"Bao","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.05.010","article-title":"Immunobiology of cholangiocarcinoma","volume":"79","author":"Tomlinson","year":"2023","journal-title":"J Hepatol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.008","article-title":"Peix J et\u00a0al: Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma","volume":"73","author":"Montal","year":"2020","journal-title":"J Hepatol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"23","DOI":"10.21037\/tgh","article-title":"The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma","volume":"4","author":"Jaklitsch","year":"2019","journal-title":"Transl Gastroenterol Hepatol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/s41419-020-03070-z","article-title":"Li X et\u00a0al: GATA6 promotes epithelial-mesenchymal transition and metastasis through MUC1\/beta-catenin pathway in cholangiocarcinoma","volume":"11","author":"Deng","year":"2020","journal-title":"Cell Death Dis"},{"key":"B93","doi-asserted-by":"publisher","first-page":"e2205148","DOI":"10.1002\/advs.202205148","article-title":"Jo JH et\u00a0al: Plasmon-Enhanced Single Extracellular Vesicle Analysis for Cholangiocarcinoma Diagnosis","volume":"10","author":"Jeong","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.05.039","article-title":"Shi G et\u00a0al: Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma","volume":"73","author":"Zhang","year":"2020","journal-title":"J Hepatol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0304","article-title":"Brown ZJ et\u00a0al: Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma","volume":"11","author":"Zhang","year":"2021","journal-title":"Cancer Discovery"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.05.043","article-title":"Malenica I et\u00a0al: Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target","volume":"77","author":"Alvisi","year":"2022","journal-title":"J Hepatol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/nature22991","article-title":"Peter L et\u00a0al: An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2017-0091","article-title":"Melanoma: a prototype of cancer-testis antigen-expressing Malignancies","volume":"9","author":"Faramarzi","year":"2017","journal-title":"Immunotherapy"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-1922","article-title":"Tumor-infiltrating lymphocyte therapy in melanoma: facts to the future","volume":"29","author":"Betof Warner","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29050247","article-title":"Immune checkpoint inhibitors in cancer therapy","volume":"29","author":"Shiravand","year":"2022","journal-title":"Curr Oncol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246366","article-title":"Predictive biomarkers for outcomes of immune checkpoint inhibitors (ICIs) in melanoma: A systematic review","volume":"13","author":"Baltussen","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B102","doi-asserted-by":"publisher","first-page":"15330338211039952","DOI":"10.1177\/15330338211039952","article-title":"Application of immune checkpoint inhibitors in the treatment of cholangiocarcinoma","volume":"20","author":"Zeng","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3892\/ijo","article-title":"Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review)","volume":"63","author":"Yang","year":"2023","journal-title":"Int J Oncol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jhepr.2019.06.003","article-title":"Immunobiology of cholangiocarcinoma","volume":"1","author":"Loeuillard","year":"2019","journal-title":"JHEP Rep"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2012.02.003","article-title":"Melanoma-induced immunosuppression and its neutralization","volume":"22","author":"Umansky","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2537","article-title":"Immunosuppression in melanoma immunotherapy: potential opportunities for intervention","volume":"12","author":"Lizee","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3390\/biom10081087","article-title":"Significance of immunosuppressive cells as a target for immunotherapies in melanoma and non-melanoma skin cancers","volume":"10","author":"Fujimura","year":"2020","journal-title":"Biomolecules"},{"key":"B108","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13046-023-02696-z","article-title":"Chronic psychological stress promotes breast cancer pre-metastatic niche formation by mobilizing splenic MDSCs via TAM\/CXCL1 signaling","volume":"42","author":"Zheng","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-19-0008","article-title":"Graham DK et\u00a0al: TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma","volume":"7","author":"Holtzhausen","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B110","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.immuni.2019.06.017","article-title":"Stolz DB et\u00a0al: Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8(+) T Cell-Derived Interferon-gamma","volume":"51","author":"Liu","year":"2019","journal-title":"Immunity"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2015343117","article-title":"Kiessling R et\u00a0al: Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells","volume":"117","author":"Eisinger","year":"2020","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12976","article-title":"Macrophage targeting: opening new possibilities for cancer immunotherapy","volume":"155","author":"Cassetta","year":"2018","journal-title":"Immunology"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0300-7","article-title":"Anti-inflammatory mechanisms of the novel cytokine interleukin-38 in allergic asthma","volume":"17","author":"Sun","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1111\/all.14137","article-title":"Therapeutic and prophylactic deletion of IL-4Ra-signaling ameliorates established ovalbumin induced allergic asthma","volume":"75","author":"Khumalo","year":"2020","journal-title":"Allergy"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.01.019","article-title":"Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity","volume":"127","author":"Wong","year":"2008","journal-title":"Clin Immunol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12967-020-02508-4","article-title":"Zerbi A et\u00a0al: Immune infiltrating cells in duodenal cancers","volume":"18","author":"Donisi","year":"2020","journal-title":"J Transl Med"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-3714","article-title":"Xu Y et\u00a0al: Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer","volume":"82","author":"Singh","year":"2022","journal-title":"Cancer Res"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.12.040194.002325","article-title":"Signal transduction by the B cell antigen receptor and its coreceptors","volume":"12","author":"Cambier","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11899-018-0437-y","article-title":"Immunologic milieu of mature T-cell and NK-cell lymphomas-implications for therapy","volume":"13","author":"Tse","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02781-9","article-title":"JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3\/IL-10 axis","volume":"42","author":"Chen","year":"2023","journal-title":"Oncogene"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2146860","DOI":"10.1080\/2162402X.2022.2146860","article-title":"Pawel BR et\u00a0al: Fibroblasts and macrophages cooperate to create a pro-tumorigenic and immune resistant environment via activation of TGF-beta\/IL-6 pathway in neuroblastoma","volume":"11","author":"Louault","year":"2022","journal-title":"Oncoimmunology"},{"key":"B122","doi-asserted-by":"publisher","first-page":"104119","DOI":"10.1016\/j.cellimm.2020.104119","article-title":"The roles of tumor-associated macrophages in tumor angiogenesis and metastasis","volume":"353","author":"Fu","year":"2020","journal-title":"Cell Immunol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004076","article-title":"Eder JP et\u00a0al: Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naive or experienced for immune checkpoint blockade","volume":"10","author":"Gomez-Roca","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv474","article-title":"Stremitzer S et\u00a0al: Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials","volume":"26","author":"Sunakawa","year":"2015","journal-title":"Ann Oncol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-1824","article-title":"Riedel RF et\u00a0al: Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab","volume":"26","author":"Keung","year":"2020","journal-title":"Clin Cancer Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1451474\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T04:27:12Z","timestamp":1725337632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1451474\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":125,"alternative-id":["10.3389\/fimmu.2024.1451474"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1451474","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,3]]},"article-number":"1451474"}}